Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.63 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.63 |
| ▸ | ACP1 | P24666 | 1/20 | 0.63 |
| ▸ | PDE4A | P27815 | 1/20 | 0.63 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.63 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.63 |
| ▸ | PNPO | Q9NVS9 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | SGPL1 | O95470 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.37 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.36 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridoxamine Phosphate Anhydrous SCHEMBL43832 | 1.00 | ESR1 (0.63) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| Pyridoxamine Phosphate Anhydrous SCHEMBL10942609 | 0.99 | ESR1 (0.61) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL16171284 | 0.90 | LMNA (0.57) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL2683971 | 0.90 | LMNA (0.60) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL13176882 | 0.87 | ESR1 (0.64) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL29384180 | 0.87 | ESR1 (0.64) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL43880 | 0.87 | ESR1 (0.64) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| Water SCHEMBL371432 | 0.86 | ESR1 (0.63) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| Ammonia Solution, Strong SCHEMBL31241292 | 0.86 | ESR1 (0.63) | ESR1PTGS1ACP1PDE4AP2RX1 | |
| SCHEMBL16420385 | 0.86 | ESR1 (0.63) | ESR1PTGS1ACP1PDE4AP2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118879891-A | Method for evaluating PE (polyethylene) based on intestinal flora | 广州市番禺区妇幼保健院(广州市番禺区何贤纪念医院) | 2024-11-01 | — | — | CN | claimed |
| WO-2026085618-A1 | METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION | YYZ PHARMATECH INC. (CA) | 2026-04-30 | — | — | WO | disclosed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-120041414-A | D-erythrose-4-phosphate dehydrogenase mutant and application thereof in vitamin B production6Application of strain construction | 东华大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-118974266-A | Enantioselective process for preparing chiral amine intermediates | 约翰内斯堡威特沃特斯兰德大学 | 2024-11-15 | — | — | CN | disclosed |
| CN-118879891-A | Method for evaluating PE (polyethylene) based on intestinal flora | 广州市番禺区妇幼保健院(广州市番禺区何贤纪念医院) | 2024-11-01 | — | — | CN | disclosed |
| WO-2024216099-A1 | SYSTEMS AND METHODS FOR BACTERIA-SPECIFIC PRO-PHOTOSENSITIZERS TO POTENTIATE BACTERICIDE | THE GENERAL HOSPITAL CORPORATION (US) | 2024-10-17 | — | — | WO | disclosed |
| EP-4444111-A1 | PRENATAL SUPPLEMENT COMPOSITIONS FOR INCREASING BREASTMILK MICRONUTRIENT LEVELS | Société des Produits Nestlé S.A. (CH) | 2024-10-16 | — | — | EP | disclosed |
| CN-118531155-A | Main effect QTL locus molecular marker for regulating and controlling vitamin B6 content of rice grains and application thereof | 浙江师范大学 | 2024-08-23 | — | — | CN | disclosed |
| CN-118401537-A | Pyridoxal-5-phosphate (P5P) analogues | 加美生物研究公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-118354679-A | Prenatal supplement composition for increasing breast milk micronutrient levels | 雀巢产品有限公司 | 2024-07-16 | — | — | CN | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |
| CN-116814586-A | Pyridoxal kinase mutant and application thereof in pyridoxine phosphate synthesis | 美邦美和生物科技有限公司 | 2023-09-29 | — | — | CN | disclosed |
| EP-4232598-A1 | MASS SPECTROMETRY-BASED METHODS AND KITS FOR NUCLEIC ACID DETECTION AND DISEASE DIAGNOSTIC | YYZ Pharmatech Inc. (CA) | 2023-08-30 | — | — | EP | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| CN-115040513-B | Application of vitamin B6 and preparation thereof in preparation of medicines for preventing and/or treating infection or inflammation-related diseases | 合肥瀚微生物科技有限公司 | 2023-06-16 | — | — | CN | disclosed |
| WO-2023104892-A1 | PRENATAL SUPPLEMENT COMPOSITIONS FOR INCREASING BREASTMILK MICRONUTRIENT LEVELS | Société des Produits Nestlé S.A. (CH) | 2023-06-15 | — | — | WO | disclosed |
| EP-4157250-A1 | METHODS FOR THE TREATMENT OF INFANTILE SPASMS USING MEDIUM CHAIN TRIGLYCERIDES | Cerecin Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| CN-115884766-A | Methods for treating infantile spasms using medium chain triglycerides | 睿升公司 | 2023-03-31 | — | — | CN | disclosed |
| WO-2022087730-A1 | MASS SPECTROMETRY-BASED METHODS AND KITS FOR NUCLEIC ACID DETECTION AND DISEASE DIAGNOSTIC | YYZ PHARMATECH INC. (CA) | 2022-05-05 | — | — | WO | disclosed |